rs61742739
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_003041.4(SLC5A2):āc.1961A>Gā(p.Asn654Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00703 in 1,613,962 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003041.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A2 | NM_003041.4 | c.1961A>G | p.Asn654Ser | missense_variant | Exon 14 of 14 | ENST00000330498.4 | NP_003032.1 | |
RUSF1 | NM_022744.4 | c.*358T>C | 3_prime_UTR_variant | Exon 13 of 13 | ENST00000327237.7 | NP_073581.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A2 | ENST00000330498.4 | c.1961A>G | p.Asn654Ser | missense_variant | Exon 14 of 14 | 1 | NM_003041.4 | ENSP00000327943.3 | ||
RUSF1 | ENST00000327237 | c.*358T>C | 3_prime_UTR_variant | Exon 13 of 13 | 1 | NM_022744.4 | ENSP00000317579.2 |
Frequencies
GnomAD3 genomes AF: 0.00515 AC: 783AN: 152180Hom.: 7 Cov.: 33
GnomAD3 exomes AF: 0.00560 AC: 1391AN: 248370Hom.: 9 AF XY: 0.00559 AC XY: 752AN XY: 134486
GnomAD4 exome AF: 0.00722 AC: 10556AN: 1461664Hom.: 58 Cov.: 31 AF XY: 0.00693 AC XY: 5042AN XY: 727104
GnomAD4 genome AF: 0.00514 AC: 783AN: 152298Hom.: 7 Cov.: 33 AF XY: 0.00494 AC XY: 368AN XY: 74482
ClinVar
Submissions by phenotype
Familial renal glucosuria Pathogenic:1Uncertain:2Benign:1
- -
NM_003041.3:c.1961A>G in the SLC5A2 gene has an allele frequency of 0.03 in Ashkenazi Jewish subpopulation in the gnomAD database. Although 10 homozygous occurrences are observed in the gnomAD database, renal glucosuria is not lethal in young age. Therefore we did not count this as a strong benign evidence. One individual with renal glucosuria, was a compound heterozygote for this variant and p.Q167fsX186 mutation (PMID: 14614622). We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: BS1; PM3. -
A heterozygous missense variant was identified, NM_003041.3(SLC5A2):c.1961A>G in exon 14 of 14 of the SLC5A2 gene. This substitution is predicted to create a minor amino acid change from asparagine to serine at position 654 of the protein, NP_003032.1(SLC5A2):p.(Asn654Ser). The asparagine at this position has moderate conservation (100 vertebrates, UCSC), but is located within the SLC5sbd_SGLT2 domain. In silico software predictions of the pathogenicity of this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.54% (1489 heterozygotes, 10 homozygotes). The variant has been previously reported pathogenic in patients with renal glucosuria (ClinVar, Calado, J. et al. (2004)). Based on information available at the time of curation, this variant has been classified as LIKELY BENIGN. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Uncertain:1Benign:1
- -
Observed in multiple individuals with glucosuria in the literature; the majority of these individuals had a second variant in the SLC5A2 gene, although it is not known whether the variants occurred on the same (in cis) or on opposite alleles (in trans) in some cases (PMID: 37349938, 15110322, 14614622, 18622023, 31672324; Moscoso J et al. (2023) International Journal of Medical Reviews and Case Reports. 7 (6):53-56 https://www.mdpub.net/?mno=152000); Identified as a single heterozygous variant in a patient with chronic kidney disease in the literature, however, additional clinical information was not provided (PMID: 33226606); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 37516996, 18622023, Moscoso[article]2023, 25333069, 31672324, 14569097, 15110322, 30476936, 35982159, 33057194, 14614622, 33226606, 37349938, 37240725) -
not specified Uncertain:1
- -
SLC5A2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at